Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cd4+ Lymphocyte Deficiency”

164 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 164 results

Early research (Phase 1)Study completedNCT00000886
What this trial is testing

A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Large-scale testing (Phase 3)Study completedNCT00480792
What this trial is testing

Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 437
Testing effectiveness (Phase 2)Study completedNCT00002435
What this trial is testing

Thymic Humoral Factor (THF Gamma 2) in HIV-Infected Patients

Who this might be right for
HIV Infections
Pharmacia
Post-approval studies (Phase 4)Study completedNCT04192487
What this trial is testing

Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea

Who this might be right for
Acquired Immunodeficiency SyndromeHealthy VolunteersHIV/AIDS+2 more
Napo Pharmaceuticals, Inc. 17
Not applicableStudy completedNCT00002369
What this trial is testing

A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Bristol-Myers Squibb 200
Early research (Phase 1)UnknownNCT00005120
What this trial is testing

The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Sarawak MediChem Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT01734850
What this trial is testing

Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection

Who this might be right for
Human Immunodeficiency Virus
Calimmune, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT00001122
What this trial is testing

An Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 74
Early research (Phase 1)Study completedNCT00000729
What this trial is testing

Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableStudy completedNCT00051831
What this trial is testing

Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 19
Early research (Phase 1)UnknownNCT00006209
What this trial is testing

Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Aaron Diamond AIDS Research Center 24
Testing effectiveness (Phase 2)Study completedNCT00376935
What this trial is testing

Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 99
Testing effectiveness (Phase 2)Study completedNCT00000948
What this trial is testing

Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Testing effectiveness (Phase 2)Study completedNCT03568812
What this trial is testing

The Role of Probiotics in HIV Patients With Immunological Non-Responder

Who this might be right for
HIV InfectionsImmunological Abnormality
Indonesia University 80
Testing effectiveness (Phase 2)Study completedNCT00000747
What this trial is testing

An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableStudy completedNCT03549546
What this trial is testing

Expression of the Inhibitory Receptors on Lymphocytes T Cells After Lung Cancer Surgery.

Who this might be right for
Lung CancerSurgery
Centre Hospitalier Universitaire de Saint Etienne 31
Testing effectiveness (Phase 2)Study completedNCT00001354
What this trial is testing

Interleukin-2 Therapy for HIV Infection - Supplemental Procedures

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT00002161
What this trial is testing

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3

Who this might be right for
HIV Infections
Gilead Sciences 400
Testing effectiveness (Phase 2)Study completedNCT00001688
What this trial is testing

A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 25
Early research (Phase 1)Study completedNCT00000777
What this trial is testing

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)

Who this might be right for
HIV InfectionsPregnancyHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 24
Load More Results